Andere Kunden interessierten sich auch für
![Myeloproliferative Disorders]( "Myeloproliferative Disorders")
Myeloproliferative Disorders83,99 €![Haematology]( "Haematology")
Haematology31,99 €![Myeloproliferative Neoplasms, an Issue of Hematology/Oncology Clinics of North America]( "Myeloproliferative Neoplasms, an Issue of Hematology/Oncology Clinics of North America")
Myeloproliferative Neoplasms, an Issue of Hematology/Oncology Clinics of North America74,99 €![Advances in Eicosanoid Research]( "Advances in Eicosanoid Research")
Advances in Eicosanoid Research38,99 €![Signal Transduction in Testicular Cells]( "Signal Transduction in Testicular Cells")
Signal Transduction in Testicular Cells39,99 €![Cell Adhesion Molecules]( "Cell Adhesion Molecules")
Cell Adhesion Molecules39,99 €![The Cardiovascular Adrenergic System]( "The Cardiovascular Adrenergic System")
The Cardiovascular Adrenergic System76,99 €
This book contains a series of contributions from internationally renowned academics with special expertise in one or other diseases which collectively are grouped under the heading myeloproliferative disorders. For the editors this term includes Ph-positive chronic myeloid leukemia but also the various Ph-negative variants, some of which provide fascinating insights into the molecular mechanisms of leukemia. There have been many recent developments in understanding the Pathophysiology and a number of therapeutic innovations in this area. One particular merit of this book is the speed with which it has been produced - an important factor in this very rapidly moving field.
From the reviews:
"... a superb summary of the topic, is a modern synthesis of Dameshek's adventurous thinking. ... Myeloproliferative Disorders is an important contribution to hematology. It arrives at a time when the study and treatment of these important diseases is at a crossroads, a time when hematologists everywhere have come to expect that the next great leap forward will come soon. For me, this book will sit on the shelf next to the first edition of Dameshek's Leukemia. ..." (Robert Schwartz, New England Journal of Medicine, 356/ 24, June 2007)
"First identified and named by William Dameshek in 1951, myeloproliferative disorders have become 'landmarks in the history of malignant disease ... on which progress in understanding and treating other malignancies ... and indeed solid tumors can be based.' ... it 'should be of interest to medical students who find the specialty of hematology truly fascinating.' For other physicians and for patients, this reference provides a needed understanding of avant-garde medical research." (William H. Wehrmacher, JAMA, Vol. 298, 2007)
"... a superb summary of the topic, is a modern synthesis of Dameshek's adventurous thinking. ... Myeloproliferative Disorders is an important contribution to hematology. It arrives at a time when the study and treatment of these important diseases is at a crossroads, a time when hematologists everywhere have come to expect that the next great leap forward will come soon. For me, this book will sit on the shelf next to the first edition of Dameshek's Leukemia. ..." (Robert Schwartz, New England Journal of Medicine, 356/ 24, June 2007)
"First identified and named by William Dameshek in 1951, myeloproliferative disorders have become 'landmarks in the history of malignant disease ... on which progress in understanding and treating other malignancies ... and indeed solid tumors can be based.' ... it 'should be of interest to medical students who find the specialty of hematology truly fascinating.' For other physicians and for patients, this reference provides a needed understanding of avant-garde medical research." (William H. Wehrmacher, JAMA, Vol. 298, 2007)